News & Insights
Follow our progress as we advance our approach designed to restore what Cystic Fibrosis takes away.
Featured
Vienna, Austria β September 6β11, 2026 β Aceso Therapeutics is presenting new research at the 38th European Peptide Symposium, highlighting promising advances in peptide-based approaches to address key challenges in
All news
Browse the latest from ACESO across company news, research, publications, and industry events.
ACESO continues to build a scientific foundation for a new generation of cystic fibrosis therapy focused on patients underserved by current treatment options. ACESO Therapeutics is advancing a therapeutic strategy
AcesoTherapeutics will be attending Deeptech Connect on November 4, 2025 β the flagship event organized by the #SATT network, showcasing the best of French #Deeptech startups. π― A great opportunity to discover an investment opportunity in our novel cystic
π Congratulations to Magali Taulan-Cadars and Prisca Boisguerin for winning the 2025 Innovation Β« Coup de cΕur Β» Award with their StabCFTR project, aiming to improve care for cystic fibrosis
CFTR stabilizers as therapeutic tools in cystic fibrosis
ACESO continues to build a scientific foundation for a new generation of cystic fibrosis therapy focused on patients underserved by current treatment options. ACESO Therapeutics is advancing a therapeutic strategy
π Congratulations to Magali Taulan-Cadars and Prisca Boisguerin for winning the 2025 Innovation Β« Coup de cΕur Β» Award with their StabCFTR project, aiming to improve care for cystic fibrosis
Vienna, Austria β September 6β11, 2026 β Aceso Therapeutics is presenting new research at the 38th European Peptide Symposium, highlighting promising advances in peptide-based approaches to address key challenges in
AcesoTherapeutics will be attending Deeptech Connect on November 4, 2025 β the flagship event organized by the #SATT network, showcasing the best of French #Deeptech startups. π― A great opportunity to discover an investment opportunity in our novel cystic
Stay in the loop
Stay in the loop
Get in touch
Whether you’re an investor, strategic partner, or member of the scientific community β we’d be glad to talk.
